Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey M Fowler

Showing results (41-50 of 102) with videos related to

Pageof 11
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 14, 2009
Outpatient platinum-taxane intraperitoneal chemotherapy regimen for ovarian cancerLeigh G Seamon, Matthew J Carlson, Debra L Richardson, et al.
Gynecologic Oncology|June 25, 2019
Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739)Floor J Backes, David Cohen, Ritu Salani, et al.
Gynecologic Oncology|January 27, 2009
Minimally invasive comprehensive surgical staging for endometrial cancer: Robotics or laparoscopy?Leigh G Seamon, David E Cohn, Melissa S Henretta, et al.
American Journal of Obstetrics and Gynecology|April 25, 2003
Pre-emptive analgesia in gynecologic surgical procedures: preoperative wound infiltration with ropivacaine in patients who undergo laparotomy through a midline vertical incisionGlenn M Updike, Tom P Manolitsas, David E Cohn, et al.
Gynecologic Oncology|September 5, 2008
CA125 decline in ovarian cancer patients treated with intravenous versus intraperitoneal platinum-based chemotherapyDebra L Richardson, Leigh G Seamon, Matthew J Carlson, et al.
Gynecologic Oncology|January 24, 2016
Survival outcomes of obese patients in type II endometrial cancer: Defining the prognostic impact of increasing BMICaroline C Billingsley, Catherine Cansino, David M O'Malley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patientsCarl Morrison, Vanna Zanagnolo, Nilsa Ramirez, et al.
Gynecologic Oncology|October 3, 2008
Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancerDebra L Richardson, Floor J Backes, Leigh G Seamon, et al.
Gynecologic Oncology|August 12, 2011
A black raspberry extract inhibits proliferation and regulates apoptosis in cervical cancer cellsZhaoxia Zhang, Thomas J Knobloch, Leigh G Seamon, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 29, 2015
Robotic Hysterectomy for Endometrial Cancer in Obese Patients With Comorbidities: Evaluating Postoperative ComplicationsFloor J Backes, Maggie Rosen, Margaret Liang, et al.
Pageof 11

Showing results (41-50 of 102) with videos related to

Sort By:
Pageof 11
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 14, 2009
Outpatient platinum-taxane intraperitoneal chemotherapy regimen for ovarian cancerLeigh G Seamon, Matthew J Carlson, Debra L Richardson, et al.
Gynecologic Oncology|June 25, 2019
Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739)Floor J Backes, David Cohen, Ritu Salani, et al.
Gynecologic Oncology|January 27, 2009
Minimally invasive comprehensive surgical staging for endometrial cancer: Robotics or laparoscopy?Leigh G Seamon, David E Cohn, Melissa S Henretta, et al.
American Journal of Obstetrics and Gynecology|April 25, 2003
Pre-emptive analgesia in gynecologic surgical procedures: preoperative wound infiltration with ropivacaine in patients who undergo laparotomy through a midline vertical incisionGlenn M Updike, Tom P Manolitsas, David E Cohn, et al.
Gynecologic Oncology|September 5, 2008
CA125 decline in ovarian cancer patients treated with intravenous versus intraperitoneal platinum-based chemotherapyDebra L Richardson, Leigh G Seamon, Matthew J Carlson, et al.
Gynecologic Oncology|January 24, 2016
Survival outcomes of obese patients in type II endometrial cancer: Defining the prognostic impact of increasing BMICaroline C Billingsley, Catherine Cansino, David M O'Malley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patientsCarl Morrison, Vanna Zanagnolo, Nilsa Ramirez, et al.
Gynecologic Oncology|October 3, 2008
Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancerDebra L Richardson, Floor J Backes, Leigh G Seamon, et al.
Gynecologic Oncology|August 12, 2011
A black raspberry extract inhibits proliferation and regulates apoptosis in cervical cancer cellsZhaoxia Zhang, Thomas J Knobloch, Leigh G Seamon, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 29, 2015
Robotic Hysterectomy for Endometrial Cancer in Obese Patients With Comorbidities: Evaluating Postoperative ComplicationsFloor J Backes, Maggie Rosen, Margaret Liang, et al.
Pageof 11